Analytical and clinical comparison of three nucleic acid amplification tests for SARS-CoV-2 detection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 and has quickly become a worldwide pandemic. In response, many …
December 2019 and has quickly become a worldwide pandemic. In response, many …
Clinical performance of SARS-CoV-2 molecular tests
Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical …
gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical …
[HTML][HTML] Current status of diagnostic testing for SARS-CoV-2 infection and future developments: a review
J Gao, L Quan - … science monitor: international medical journal of …, 2020 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, SARS-
CoV-2, has infected more than 50.6 million individuals and caused over 1.2 million deaths …
CoV-2, has infected more than 50.6 million individuals and caused over 1.2 million deaths …
Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
K Uhteg, J Jarrett, M Richards, C Howard… - Journal of Clinical …, 2020 - Elsevier
In December 2019, a novel coronavirus (SARS-CoV-2) was first isolated from Wuhan city,
China and within three months, the global community was challenged with a devastating …
China and within three months, the global community was challenged with a devastating …
SARS-CoV-2 testing: trials and tribulations
A Babiker, CW Myers, CE Hill… - American journal of …, 2020 - academic.oup.com
Coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), started in the Wuhan province of China and is now …
syndrome coronavirus 2 (SARS-CoV-2), started in the Wuhan province of China and is now …
[PDF][PDF] Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020
World Health Organization - 2020 - apps.who.int
Background Since the beginning of the COVID-19 pandemic, laboratories have been using
nucleic acid amplification tests (NAATs), such as real time reverse transcription polymerase …
nucleic acid amplification tests (NAATs), such as real time reverse transcription polymerase …
Laboratory diagnosis of COVID-19: current issues and challenges
YW Tang, JE Schmitz, DH Persing… - Journal of clinical …, 2020 - Am Soc Microbiol
The COVID-19 outbreak has had a major impact on clinical microbiology laboratories in the
past several months. This commentary covers current issues and challenges for the …
past several months. This commentary covers current issues and challenges for the …
False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives
DS Mouliou, KI Gourgoulianis - Expert review of respiratory …, 2021 - Taylor & Francis
ABSTRACT Introduction: A novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) was reported via nucleic acid identification in December, 2019. Accuracy of SARS …
CoV-2) was reported via nucleic acid identification in December, 2019. Accuracy of SARS …
Nucleic acid-based diagnostic tests for the detection SARS-CoV-2: an update
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) began as a cluster of pneumonia cases in Wuhan, China …
coronavirus 2 (SARS-CoV-2) began as a cluster of pneumonia cases in Wuhan, China …
The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in …
Diagnostic testing for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
infection remains a challenge around the world, especially in low-middle-income countries …
infection remains a challenge around the world, especially in low-middle-income countries …